FinMedium

A Community Sourced Financial Web Magazine

Skip to content
Menu
  • Home
  • Categories
    • FinMedium Research Desk
    • Educational
    • Concall Summaries
    • Investing
    • Decision Making
    • Financial Planning
    • Book Summaries
    • Companies
    • Mutual Funds
  • हिन्दी
  • Submit Article
  • Contributors
  • About

Category: CDMO

Ultimate Guide to CRAMS or CDMO with various Companies to Track
CDMO

Ultimate Guide to CRAMS or CDMO with various Companies to Track

Posted on November 13, 2020 by Shuchi Nahar

Reading Time: 2 minutes   Ultimate Guide to CRAMS or CDMO  with various companies to track What are CRAMS? CRAMS is defined as the process of outsourcing research services/…

The Massive Future of Pharma Contract Manufacturing Beyond 2020
CDMO

The Massive Future of Pharma Contract Manufacturing Beyond 2020

Posted on October 17, 2020October 17, 2020 by Shuchi Nahar

Reading Time: 7 minutes Written By: Shuchi Nahar | Shuchi’s Blog | Linkedin Profile Contract Manufacturing (CDMO) Industry Insight The global pharmaceutical contract manufacturing & contract research market size was valued at over USD…

Neuland Labs Company Snapshot
Api

Neuland Labs Company Snapshot

Posted on September 5, 2020September 6, 2020 by Shuchi Nahar

Reading Time: 4 minutes Written By: Shuchi.P.Nahar | Twitter Handle: @shuchi_nahar Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s…

Evolution in Biosimilars, Opportunities and Market size Growth Ahead
biosimilar

Evolution in Biosimilars, Opportunities and Market size Growth Ahead

Posted on August 29, 2020 by Shuchi Nahar

Reading Time: 3 minutes Figure 4: Evolution of Biosimilars and rising approvals Source: Bill of Health – Harvard Law Biosimilars have a bright future if additional work is done…

What is so attractive about CDMO’s in Pharmaceutical Companies?
acquisitions

What is so attractive about CDMO’s in Pharmaceutical Companies?

Posted on July 26, 2020 by Shuchi Nahar

Reading Time: 6 minutes CDMO’s to be considered as next stepping stone for Pharma Companies… SHUCHI.P.NAHAR Link: https://myweekendspot.blogspot.com/2020/07/a-masterclass-on-global-custom.html In recent years, pharmaceutical outsourcing has grown in popularity amongst drug…

Pharma Sector by Aditya Khemka
Aditya Khemka

Pharma Sector by Aditya Khemka

Posted on June 14, 2020 by Shuchi Nahar

Reading Time: 4 minutes SHUCHI.P.NAHAR Pharma business is divided into two models: Domestic  Export  Domestic Model This model is typically like a FMCG business. In domestic markets those pharma…

Understanding Pharma Growth from various important corners
AIDS

Understanding Pharma Growth from various important corners

Posted on May 17, 2020 by Shuchi Nahar

Reading Time: 9 minutes “Practitioners’ Insights: Understanding Pharma” Shuchi.P.Nahar India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50% of global demand for…

What is FinMedium?

FinMedium is a financial web-magazine that publishes the insightful and sharp ideas of the financial thinkers and writers.

Our mission is to help people make wise decisions on the matters that matter the most – Finances.

© Copyright 2021 – FinMedium
Wisteria Theme by WPFriendship ⋅ Powered by WordPress